Variantyx Company
Variantyx, a leader in high complexity hereditary disease testing, launched Genomic Unity® Prenatal Analysis test for high-risk pregnancies, entering women’s health market.
Industry:
Pregnancy & Nursing
Headquarters:
Framingham, Massachusetts, United States
Founded Date:
01-01-2014
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
10
Total Funding:
$100,500,000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-10-18
Last Funding Type:
Debt Financing
Register and Claim Ownership